Table 4

Biochemical data for patients with PROSC mutations

P1* P2 P3 P4
Age at sampling11 y12 y8 d6 w5 dNA
Pyridoxine dosage (mg/day)300, 2 SD300, 2 SD24 hours after SD of 100 mg i.v.2 weeks on 100 mg/day, 2 SDNo
PLASMA
Amino acids (µmol/L)Ref.Ref.Ref.NA
Alanine330416152–508445 549 100–439209195–675
Valine244253142–27813118560–294134120–560
Isoleucine686638–94678928–953235–175
Leucine12613276–16816815045–1608290–290
Glycine190217148–324 574 35060–380326105–445
Phenylalanine545938–78326023–756125–145
Proline17128075–307 434 31050–298140120–620
Tyrosine646640–925810720–1207650–210
Others metabolitesNANA
PA (µmol/L)1.670.22–3.720.8 (4 y)0.22–3.72
AASA (µmol/L)0.1
CSF
Amino acids (µmol/L)39 cells/mLRef.NANA
Lactate (mmol/L)1.331.1–1.8
Alanine 53.7 59 23–39.5
Valine 43.7 33.1 14.8–22.5
Isoleucine 13.8 15.1 4.6–8.6
Leucine 35.6 29.3 11.0–18.7
Glycine 12.5 11.5 3.5–9.3
Phenylalanine 22.6 13.97.0–13.2
ProlineNANA
Tyrosine21.9 30 7.1–21.5
HomocarnosineNANA
Neurotransmitters (nmol/L)Ref.NANA
HVA918484–1446
5-HIAA386302–952
3-ortho-Methyldopa6<310
L-Dopand<15
5-OH-Tryptophane13<20
5-MTHF15862–287
Free GABA48§ 17–67
Total GABA7340§ 4200–13400
URINE
AASA0.1NANANA
Organic acidsnormalnormalNANA
  • *Samples measured at the Department of Clinical Chemistry and Biochemistry, University Children’s Hospital Zurich.

  • Samples measured at the Division of Inherited Metabolic Diseases, University of Heidelberg.

  • Samples measured at the Department of Pediatrics, Vrije Universiteit Amsterdam.

  • §Samples measured at the Institute Giannina Gaslini, Genova.

  • Abnormal values are given in bold.

  • AASA, alpha-aminoadipic semialdehyde; CSF, cerebro spinal fluid; d, days; GABA, gamma-aminobutyric acid; 5-HIAA, 5-hydroxyindoleacetic acid; HVA, homovanillic acid; 5-MTHF, 5-methyltetrahydrofolate; NA, not available; PA, pipecolic acid; SD, single dosage; w, weeks; y, years.

  • Abnormal values are given in bold.